The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
RTS,S/AS01 is the falciparum malaria vaccine candidate that is most advanced in development, globally.<br/> In a large clinical trial in sub-Saharan African children, the protection conferred by RTS,S/AS01 was found to rapidly decline, particularly in infants. <br/>Although RTS,S/AS01 wa...
Auteurs principaux: | Gosling, R, von Seidlein, L |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Public Library of Science
2015
|
Documents similaires
-
The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
par: Roly Gosling, et autres
Publié: (2016-04-01) -
RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
par: Bejon, P, et autres
Publié: (2009) -
Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
par: Shima Mahmoudi, et autres
Publié: (2017-09-01) -
The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
par: Juliette Fortpied, et autres
Publié: (2020-06-01) -
RTS,S/AS01 malaria vaccine in African children.
par: Hill, A
Publié: (2012)